Loomis, Sayles & Company’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Loomis, Sayles & Company’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-272,007	Closed	-$59M	–	949
2021 Q1	$59M	Buy	272,007 +60,817	+29%	+$11.4M	0.08%	114
2020 Q4	$24.4M	Sell	211,190 -1,355	-0.6%	-$152K	0.03%	235
2020 Q3	$20.7M	Buy	212,545 +3,985	+2%	+$459K	0.03%	227
2020 Q2	$25.6M	Buy	208,560 +47,092	+29%	+$5.34M	0.04%	181
2020 Q1	$14.1M	Buy	+161,468	New	+$17.1M	0.03%	236

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Loomis, Sayles & Company's GWPH Position: Q2 2021 in Review

Loomis, Sayles & Company sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 272,007 shares — an estimated $59M sold.

Loomis, Sayles & Company first reported a position in GWPH in Q1 2020 and held it in 5 quarters. The position peaked at $59M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Loomis, Sayles & Company reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Loomis, Sayles & Company sold 272,007 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $59M.
Loomis, Sayles & Company first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 5 quarters.
Loomis, Sayles & Company's GW Pharmaceuticals Plc American Depositary Shares position peaked at $59M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.